A Study of Revumenib and Mezigdomide in People With Leukemia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Revumenib and Mezigdomide in People With Leukemia	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute biphenotypic leukemia, acute leukemia, acute myeloid leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, mixed phenotype acute leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 1 / Phase 2	2026-06-22		NCT07356154

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Memorial Sloan Kettering Cancer Center	753

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
City of Hope Cancer Center (Data Collection Only)	Duarte	United States	4
MD Anderson Cancer Center (Data Collection Only)	Houston	United States	9
Memorial Sloan Kettering at Basking Ridge (All Protocol Activities)	Basking Ridge	United States	14
Memorial Sloan Kettering Bergen (All Protocol Activities)	Montvale	United States	82
Memorial Sloan Kettering Cancer Center (All Protocol Activities)	New York	United States	230
Memorial Sloan Kettering Monmouth (All Protocol Activities)	Middletown	United States	92
Memorial Sloan Kettering Nassau (All Protocol Activities)	Rockville Centre	United States	27
Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities)	Commack	United States	9
Memorial Sloan Kettering Westchester (Limited Protocol Activities)	Harrison	United States	166
University of North Carolina (Data Collection Only)	Chapel Hill	United States	2